Federal advisers on Friday declined to recommend boosters for Americans as young as 16 who took the Pfizer vaccine more than six months ago.
Following Friday's vote, the company said it would continue working with the FDA.
Among the concerns by health experts is the lack of safety data on young people related to boosters, particularly in light ofWhile many Americans have already opted for third shots, with doctors administering them"off-label," it's up to independent federal regulators to decide how the vaccines are labeled and administered.The debate has become unusually charged, in part because of White House involvement.
If the FDA signs off on the latest plan for boosters for seniors and health care workers, the CDC also has to weigh in. A key meeting is planned Wednesday by a separate group of experts that advises the CDC and will likely discuss who exactly should get the extra doses.In this Aug. 25, 2012, file photo, a healthcare worker administers a third dose of the Pfizer-BioNTech COVID-19 vaccine at a senior living facility in Worcester, Penn.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA advisory panel rejects widespread Pfizer booster shotsWASHINGTON (AP) — An influential federal advisory panel overwhelmingly rejected a plan Friday to offer Pfizer booster shots against COVID-19 to most Americans, dealing a heavy blow to the Biden administration’s effort to shore up people’s protection amid the highly contagious delta variant.
Read more »
FDA advisers vote to oppose Pfizer/BioNTech COVID-19 vaccine boosterA panel of outside advisers to the U.S. Food and Drug Administration on Friday voted against approval of a booster dose of the Pfizer Inc /BioNTech SE COVID-19 vaccine for people aged 16 and older.
Read more »
FDA Advisory Panel Rejects Widespread Pfizer Vaccine Booster ShotsThe 16-2 vote is a blow to the Biden administration's plans for giving booster shots to most Americans.
Read more »